Human Metastatic Cholangiocarcinoma Patient-Derived Xenografts and Tumoroids for Preclinical Drug EvaluationQueralt Serra-Camprubí, Tian V. Tian, Helena Verdaguer et al.|Clinical Cancer Research|2022Cited by 22
SRC inhibition enables formation of a growth suppressive MAGI1-PP2A complex in isocitrate dehydrogenase-mutant cholangiocarcinomaIris Sze Ue Luk, Sita Kugel, Supriya K. Saha et al.|Science Translational Medicine|2024Cited by 15
The potential of patient-derived organoids in precision medicine of biliary tract cancerMariana Yáñez-Bartolomé, Tian V. Tian, Teresa Macarulla|Cell Reports Medicine|2023Cited by 10
NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblastsJosep Amengual, Javier Vaquero, Ester Gonzalez‐Sanchez et al.|Signal Transduction and Targeted Therapy|2025Cited by 8
Generation of Metastatic Cholangiocarcinoma Patient-Derived Xenograft ModelsMariana Yáñez-Bartolomé, Tian V. Tian, Queralt Serra-Camprubí et al.|Methods in molecular biology|2024Cited by 2